Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKTS NASDAQ:AMRN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKTSAkoustis Technologies$0.07$0.03▼$1.19$10.54M1.9139.87 million shs118.70 million shsAMRNAmarin$15.40-0.5%$15.59$7.08▼$17.49$318.99M0.8466,436 shs45,962 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKTSAkoustis Technologies0.00%0.00%0.00%0.00%-54.41%AMRNAmarin-0.45%-2.65%+5.12%+32.76%+25.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKTSAkoustis TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAMRNAmarin0.2784 of 5 stars0.82.00.00.02.50.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKTSAkoustis Technologies 0.00N/AN/AN/AAMRNAmarin 1.50Reduce$12.00-22.08% DownsideCurrent Analyst Ratings BreakdownLatest AKTS and AMRN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/25/2025AMRNAmarinZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold6/25/2025AMRNAmarinThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$7.00 ➝ $12.00(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKTSAkoustis Technologies$27.38M0.00N/AN/A($0.46) per share0.00AMRNAmarin$219.36M1.45N/AN/A$22.45 per share0.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKTSAkoustis Technologies-$167.95MN/A0.00N/AN/A-524.47%-584.18%-166.76%N/AAMRNAmarin-$82.18M-$3.67N/AN/AN/A-47.22%-21.18%-15.00%10/29/2025 (Estimated)Latest AKTS and AMRN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025AMRNAmarin-$0.66-$0.03+$0.63-$0.03$45.45 million$72.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKTSAkoustis TechnologiesN/AN/AN/AN/AN/AAMRNAmarinN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKTSAkoustis Technologies1.000.320.28AMRNAmarinN/A3.262.34Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKTSAkoustis Technologies28.84%AMRNAmarin22.25%Insider OwnershipCompanyInsider OwnershipAKTSAkoustis Technologies3.30%AMRNAmarin3.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKTSAkoustis Technologies210154.59 million149.49 millionOptionableAMRNAmarin36020.71 million20.02 millionOptionableAKTS and AMRN HeadlinesRecent News About These CompaniesZacks Research Downgrades Amarin (NASDAQ:AMRN) to Hold3 hours ago | marketbeat.comAmarin Corporation PLC $AMRN Shares Acquired by Stonepine Capital Management LLCAugust 26 at 7:38 AM | marketbeat.comAmarin announces upcoming presentations at ESC Congress 2025August 25, 2025 | msn.comNew Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025August 25, 2025 | globenewswire.comAmarin (NASDAQ:AMRN) Share Price Passes Above 200 Day Moving Average - What's Next?August 23, 2025 | marketbeat.comIs Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?August 22, 2025 | zacks.comAmarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock NowAugust 14, 2025 | zacks.comAmarin (NASDAQ:AMRN) Stock Price Crosses Above 200 Day Moving Average - Here's What HappenedAugust 14, 2025 | marketbeat.comIs Amarin (AMRN) Outperforming Other Medical Stocks This Year?August 6, 2025 | zacks.comLCM Capital Management Inc Has $385,000 Position in Amarin Corporation PLC (NASDAQ:AMRN)August 6, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Stock Rating Upgraded by Wall Street ZenAugust 3, 2025 | marketbeat.comAmarin (NASDAQ:AMRN) Issues Quarterly Earnings ResultsAugust 2, 2025 | marketbeat.comZacks Research Analysts Cut Earnings Estimates for AmarinAugust 1, 2025 | marketbeat.comAmarin's Q2 Earnings & Revenues Trump Estimates, Stock RisesJuly 31, 2025 | zacks.comAmarin (NASDAQ:AMRN) Stock Price Crosses Above 200 Day Moving Average - What's Next?July 31, 2025 | marketbeat.comAmarin Corporation plc (AMRN) Q2 2025 Earnings Call TranscriptJuly 30, 2025 | seekingalpha.comAmarin Reports Second Quarter 2025 Financial ResultsJuly 30, 2025 | globenewswire.comAmarin Q2 2025 Earnings PreviewJuly 29, 2025 | msn.comAMRN - Amarin Corp PLC ADR Key Metrics - MorningstarJuly 25, 2025 | morningstar.comMAmarin Gears Up to Report Q2 Earnings: Here's What to ExpectJuly 24, 2025 | zacks.comAmarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025July 23, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAKTS and AMRN Company DescriptionsAkoustis Technologies NASDAQ:AKTSAkoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industry in the United States, Asia, Europe, and internationally. It operates through Foundry Fabrication Services and RF Filters segments. The Foundry Fabrication Services segment provides engineering review and backend packaging services. Its RF Filters segment sells amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense applications. The company was founded in 2013 and is headquartered in Huntersville, North Carolina.Amarin NASDAQ:AMRN$15.40 -0.07 (-0.45%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$15.57 +0.17 (+1.10%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It NIO Just Got Its Second Upgrade of the Month, and It’s Big Chevron Stock Outlook: Dividend Growth Meets Inflation As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes Back Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access